| |
| |
|
| Insider
Information: |
Parshall B Lynne |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,614,493 |
|
|
Indirect Shares
|
7,049,500 |
|
|
| Direct
Value |
$16,341,687 |
|
|
|
Indirect Value
|
$15,720,385 |
|
|
| Total
Shares |
12,663,993 |
|
|
| Total
Value |
$32,062,072 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -60.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Director |
2023-12-28 |
82,588 |
2016-12-15 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2014-11-03 |
5,516,305 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
Director |
2024-06-03 |
15,600 |
2020-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
306 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-06 |
4 |
AS |
$7.08 |
$22,300 |
D/D |
(3,150) |
7,002,300 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-07 |
4 |
AS |
$6.66 |
$17,322 |
D/D |
(2,600) |
6,999,700 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-08 |
4 |
AS |
$6.80 |
$12,583 |
D/D |
(1,850) |
6,997,850 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-13 |
4 |
AS |
$7.02 |
$15,788 |
D/D |
(2,250) |
6,995,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-14 |
4 |
AS |
$7.04 |
$12,324 |
D/D |
(1,750) |
6,993,850 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-15 |
4 |
AS |
$6.98 |
$10,115 |
D/D |
(1,450) |
6,992,400 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-20 |
4 |
AS |
$7.14 |
$21,424 |
D/D |
(3,000) |
6,989,400 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-21 |
4 |
AS |
$6.89 |
$17,222 |
D/D |
(2,500) |
6,986,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-22 |
4 |
AS |
$6.75 |
$35,443 |
D/D |
(5,250) |
6,981,650 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-27 |
4 |
AS |
$7.21 |
$10,821 |
D/D |
(1,500) |
6,980,150 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-28 |
4 |
AS |
$6.96 |
$13,921 |
D/D |
(2,000) |
6,978,150 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-29 |
4 |
AS |
$6.84 |
$10,254 |
D/D |
(1,500) |
6,976,650 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• • – |
2014-09-02 |
4 |
OE |
$7.25 |
$112,574 |
D/D |
11,071 |
4,749 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• • – |
2014-09-02 |
4 |
AS |
$40.24 |
$445,507 |
D/D |
(11,071) |
4,306 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-03 |
4 |
AS |
$6.95 |
$11,471 |
D/D |
(1,650) |
6,975,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-04 |
4 |
AS |
$7.11 |
$42,656 |
D/D |
(6,000) |
6,969,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-05 |
4 |
AS |
$7.07 |
$16,974 |
D/D |
(2,400) |
6,966,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-10 |
4 |
AS |
$7.70 |
$15,399 |
D/D |
(2,000) |
6,964,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-11 |
4 |
AS |
$7.83 |
$26,636 |
D/D |
(3,400) |
6,961,200 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-12 |
4 |
AS |
$7.96 |
$27,861 |
D/D |
(3,500) |
6,957,700 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-17 |
4 |
AS |
$7.43 |
$15,610 |
D/D |
(2,100) |
6,955,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-18 |
4 |
AS |
$7.40 |
$11,098 |
D/D |
(1,500) |
6,954,100 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-19 |
4 |
AS |
$7.22 |
$29,587 |
D/D |
(4,100) |
6,950,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-24 |
4 |
AS |
$7.19 |
$26,978 |
D/D |
(3,750) |
6,946,250 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-25 |
4 |
AS |
$7.12 |
$17,790 |
D/D |
(2,500) |
6,943,750 |
0 |
- |
|
306 Records found
|
|
Page 8 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
